Compounds > megestrol acetate
Page last updated: 2024-08-21

megestrol acetate and Carcinoma, Endometrioid

megestrol acetate has been researched along with Carcinoma, Endometrioid in 19 studies

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (31.58)29.6817
2010's8 (42.11)24.3611
2020's5 (26.32)2.80

Authors

AuthorsStudies
Fu, HC; Kung, FT; Lan, J; Lan, KC; Lin, H; Ou, YC; Tsai, YC; Wu, CH1
Ascione, M; Bifulco, G; Boccia, D; Buonfantino, C; Cafasso, V; De Angelis, MC; Della Corte, L; Giampaolino, P; Grasso, G; Gullo, G; Mercorio, A; Palumbo, M; Serafino, P; Verrazzo, P; Viciglione, F1
da Silva, VF; de Melo, AC; Paulino, E1
Cho, A; Kim, DY; Kim, JH; Kim, YM; Kim, YT; Lee, SW; Park, JY; Suh, DS1
Catena, U; Fanfani, F; Masciullo, V; Moroni, R; Scambia, G; Trivellizzi, N; Zannoni, G1
Li, L; Lin, J; Lou, H; Wang, F; Xu, H; Yu, A; Yu, H; Zhang, X1
Jiang, ZX; Ju, XZ; Ren, YL; Shan, BE; Sun, JM; Tu, XY; Wang, HY; Zang, RY1
Clarke, BA; Feigenberg, T; Ferguson, SE; Gien, LT; Ismiil, N; Laframboise, S; Massey, C; Simpson, AN1
Bidadi, S; Foroughi, M; Ghojazadeh, M; Melli, MS; Tabrizi, AD1
Franco, EL; Gotlieb, WH; Greenwald, ZR; Huang, LN; Wissing, MD1
Baiocco, E; Carosi, M; Corrado, G; Vizza, E1
Ergun, B; Iyibozkurt, C; Kalelioğlu, I; Topuz, S1
Hahn, HS; Hong, JS; Hong, SR; Kim, TJ; Kwon, YS; Lee, IH; Lee, KH; Lim, JY; Lim, KT; Mok, JE; Park, SJ; Shim, JU; Yoon, SG1
Kim, JY; Park, CT; Park, H; Seok, JM; Seong, SJ; Shim, JY; Yoon, BS1
Bae, DS; Kim, DY; Kim, JH; Kim, JW; Kim, KR; Kim, SM; Kim, TJ; Kim, YM; Kim, YT; Nam, JH; Park, JY; Seong, SJ1
Bae, DS; Kim, JW; Kim, SM; Kim, TJ; Nam, JH; Park, JY; Seong, SJ1
Andersen, W; Brunetto, VL; Fiorica, JV; Hanjani, P; Lentz, SS; Mannel, R1
Chang, CL; Chen, CP; Wang, KL; Wu, CC; Yang, YC1
Ayhan, A; Bozdag, G; Demirol, A; Gurgan, T1

Reviews

2 review(s) available for megestrol acetate and Carcinoma, Endometrioid

ArticleYear
Fertility-Sparing Approach in Patients with Endometrioid Endometrial Cancer Grade 2 Stage IA (FIGO): A Qualitative Systematic Review.
    BioMed research international, 2022, Volume: 2022

    Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Ki-67 Antigen; Levonorgestrel; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; NF-E2-Related Factor 2; Pregnancy; Progestins; Survivin

2022
Preserving fertility before assisted reproduction in women with endometrial carcinoma: case report and literature review.
    Reproductive biomedicine online, 2007, Volume: 15, Issue:5

    Topics: Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fertility; Humans; Megestrol Acetate; Minimally Invasive Surgical Procedures; Reproductive Techniques, Assisted

2007

Trials

3 trial(s) available for megestrol acetate and Carcinoma, Endometrioid

ArticleYear
Antiproliferative effect of metformin on the endometrium--a clinical trial.
    Asian Pacific journal of cancer prevention : APJCP, 2014, Volume: 15, Issue:23

    Topics: Adult; Antineoplastic Agents, Hormonal; Atrophy; Carcinoma, Endometrioid; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Humans; Hypoglycemic Agents; Megestrol Acetate; Metformin; Metrorrhagia

2014
Phase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study.
    Gynecologic oncology, 2004, Volume: 92, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Endometrioid; Cell Differentiation; Down-Regulation; Drug Administration Schedule; Endometrial Neoplasms; Female; Humans; Megestrol Acetate; Middle Aged; Receptors, Progesterone; Tamoxifen

2004
Reevaluating the safety of fertility-sparing hormonal therapy for early endometrial cancer.
    Gynecologic oncology, 2005, Volume: 99, Issue:2

    Topics: Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Chromosomes, Human, X; Endometrial Neoplasms; Estrogen Receptor alpha; Female; Fertility; Humans; Immunohistochemistry; Megestrol Acetate; Neoplasm Recurrence, Local; Ovarian Neoplasms; Prospective Studies; Receptors, Androgen; Receptors, Progesterone; Treatment Failure; X Chromosome Inactivation

2005

Other Studies

14 other study(ies) available for megestrol acetate and Carcinoma, Endometrioid

ArticleYear
The role of prolonged progestin treatment and factors predicting successful fertility-sparing treatment for early endometrial endometrioid adenocarcinoma.
    European journal of obstetrics, gynecology, and reproductive biology, 2021, Volume: 267

    Topics: Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Megestrol Acetate; Pregnancy; Progestins; Retrospective Studies; Treatment Outcome

2021
Endometrioid Carcinoma Arising from an Endometriosis-Associated Abdominal Wall Scar.
    The American journal of case reports, 2020, Jun-01, Volume: 21

    Topics: Abdominal Wall; Carcinoma, Endometrioid; Cicatrix; Endometrial Neoplasms; Endometriosis; Female; Humans; Hysterectomy; Megestrol Acetate; Middle Aged; Salpingo-oophorectomy

2020
Continued medical treatment for persistent early endometrial cancer in young women.
    Gynecologic oncology, 2021, Volume: 160, Issue:2

    Topics: Administration, Oral; Antineoplastic Agents, Hormonal; Biopsy; Carcinoma, Endometrioid; Disease-Free Survival; Drug Administration Schedule; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Fertility Preservation; Follow-Up Studies; Humans; Intrauterine Devices; Levonorgestrel; Magnetic Resonance Imaging; Medroxyprogesterone Acetate; Megestrol Acetate; Myometrium; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Prognosis; Retrospective Studies; Time Factors; Treatment Failure; Treatment Outcome; Ultrasonography

2021
Prognostic impact of hysteroscopic resection of endometrial atypical hyperplasia-endometrioid intraepithelial neoplasia and early-stage cancer in combination with megestrol acetate.
    American journal of obstetrics and gynecology, 2021, Volume: 224, Issue:4

    Topics: Abortion, Spontaneous; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Combined Modality Therapy; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Fertilization in Vitro; Humans; Hysteroscopy; Live Birth; Megestrol Acetate; Pregnancy; Pregnancy Rate; Prognosis; Prospective Studies

2021
Fertility Preserved Hysteroscopic Approach for the Treatment of Stage Ia Endometrioid Carcinoma.
    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2017, Volume: 27, Issue:9

    Topics: Adult; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Hysteroscopy; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Staging; Pregnancy; Retrospective Studies

2017
A prospective study of fertility-sparing treatment with megestrol acetate following hysteroscopic curettage for well-differentiated endometrioid carcinoma and atypical hyperplasia in young women.
    Archives of gynecology and obstetrics, 2013, Volume: 288, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Combined Modality Therapy; Curettage; Endometrial Neoplasms; Endometrium; Feasibility Studies; Female; Fertility Preservation; Humans; Hyperplasia; Hysteroscopy; Megestrol Acetate; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Rate; Prospective Studies; Young Adult

2013
Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin.
    Gynecologic oncology, 2014, Volume: 133, Issue:2

    Topics: Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Hysterectomy; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Grading; Organ Sparing Treatments; Pregnancy; Pregnancy Outcome; Pregnancy Rate; Reproductive Techniques, Assisted; Retrospective Studies; Treatment Outcome

2014
Does hormonal therapy for fertility preservation affect the survival of young women with early-stage endometrial cancer?
    Cancer, 2017, 05-01, Volume: 123, Issue:9

    Topics: Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Cause of Death; Cohort Studies; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Hysterectomy; Kaplan-Meier Estimate; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Grading; Propensity Score; Proportional Hazards Models; SEER Program; Time Factors; United States

2017
Progression of conservatively treated endometrial complex atypical hyperplasia in a young woman: a case report.
    Fertility and sterility, 2008, Volume: 90, Issue:5

    Topics: Abortion, Spontaneous; Adult; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma, Endometrioid; Chemotherapy, Adjuvant; Disease Progression; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Hysterectomy; Hysteroscopy; Laparoscopy; Megestrol Acetate; Neoplasm Staging; Ovariectomy; Ovulation Induction; Precancerous Conditions; Pregnancy; Radiotherapy, Adjuvant; Treatment Failure

2008
Conservative management of a patient with endometrial carcinoma desiring fertility: how to inform?
    European journal of gynaecological oncology, 2008, Volume: 29, Issue:6

    Topics: Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fertility; Humans; Megestrol Acetate; Patient Participation; Pregnancy

2008
Conservative treatment with progestin and pregnancy outcomes in endometrial cancer.
    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2009, Volume: 19, Issue:6

    Topics: Adult; Algorithms; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fertility; Follow-Up Studies; Gynecologic Surgical Procedures; Humans; Infertility, Female; Medroxyprogesterone Acetate; Megestrol Acetate; Pregnancy; Pregnancy Outcome; Progestins; Remission Induction; Retrospective Studies; Treatment Outcome; Young Adult

2009
Effectiveness of high-dose progestin and long-term outcomes in young women with early-stage, well-differentiated endometrioid adenocarcinoma of uterine endometrium.
    Archives of gynecology and obstetrics, 2012, Volume: 285, Issue:2

    Topics: Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Contraceptives, Oral, Hormonal; Female; Fertility Preservation; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Maintenance Chemotherapy; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; Retrospective Studies; Time Factors; Uterine Neoplasms; Young Adult

2012
Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002).
    European journal of cancer (Oxford, England : 1990), 2013, Volume: 49, Issue:4

    Topics: Administration, Oral; Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Cohort Studies; Endometrial Neoplasms; Female; Fertility Preservation; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Pregnancy; Prognosis; Survival Rate; Young Adult

2013
Pregnancy outcomes after fertility-sparing management in young women with early endometrial cancer.
    Obstetrics and gynecology, 2013, Volume: 121, Issue:1

    Topics: Abortion, Spontaneous; Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Disease-Free Survival; Endometrial Neoplasms; Female; Fertility Agents; Humans; Infant, Newborn; Infertility, Female; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Grading; Neoplasm Staging; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Pregnancy Rate; Pregnancy, Ectopic; Premature Birth; Retrospective Studies; Treatment Outcome; Young Adult

2013